Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Mark Abzug

Concepts (408)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Enterovirus Infections
21
2019
173
2.640
 Why?
HIV Infections
27
2022
3195
1.610
 Why?
Antiretroviral Therapy, Highly Active
9
2017
279
1.590
 Why?
Pneumococcal Vaccines
5
2021
129
1.560
 Why?
Antiviral Agents
12
2024
769
1.360
 Why?
Pregnancy Complications, Infectious
14
2015
440
1.270
 Why?
Enterovirus
9
2019
83
1.120
 Why?
Hematopoietic Stem Cell Transplantation
4
2021
699
0.900
 Why?
Immunologic Memory
3
2013
368
0.890
 Why?
Pneumococcal Infections
3
2013
104
0.860
 Why?
Immunization, Secondary
4
2021
92
0.850
 Why?
Oxadiazoles
4
2015
37
0.780
 Why?
Paralysis
4
2018
69
0.690
 Why?
Child
56
2024
22739
0.620
 Why?
Triazoles
3
2024
191
0.590
 Why?
Sinusitis
7
2013
227
0.550
 Why?
Mucositis
1
2018
20
0.540
 Why?
Anti-Retroviral Agents
8
2022
251
0.540
 Why?
Vaccination
4
2017
1428
0.530
 Why?
Meningoencephalitis
1
2017
24
0.530
 Why?
Candidiasis, Invasive
3
2024
6
0.520
 Why?
Antibodies, Bacterial
4
2013
147
0.510
 Why?
Myelitis
4
2019
107
0.510
 Why?
Influenza, Human
5
2015
624
0.500
 Why?
Theilovirus
4
2000
4
0.490
 Why?
Encephalitis
1
2017
142
0.460
 Why?
Influenza A Virus, H1N1 Subtype
3
2015
159
0.460
 Why?
Graft vs Host Disease
1
2018
279
0.450
 Why?
Encephalomyelitis, Acute Disseminated
1
2015
11
0.450
 Why?
Neonatal Sepsis
1
2015
9
0.440
 Why?
Immunocompromised Host
5
2021
202
0.440
 Why?
Central Nervous System Viral Diseases
4
2019
78
0.440
 Why?
Herpes Simplex
4
2017
99
0.430
 Why?
Influenza Vaccines
3
2015
534
0.430
 Why?
Antifungal Agents
5
2024
152
0.420
 Why?
Disease Outbreaks
6
2019
419
0.410
 Why?
Neuromyelitis Optica
1
2015
140
0.390
 Why?
CD4 Lymphocyte Count
8
2022
280
0.390
 Why?
Placenta
6
2000
787
0.380
 Why?
Adolescent
37
2024
22573
0.370
 Why?
Child, Preschool
28
2024
11868
0.370
 Why?
Humans
89
2024
145763
0.370
 Why?
Drug Discovery
1
2013
153
0.370
 Why?
Measles Vaccine
1
2012
19
0.370
 Why?
Neuromuscular Diseases
3
2019
145
0.370
 Why?
Infant, Newborn
25
2018
6464
0.360
 Why?
Infant
27
2024
10090
0.360
 Why?
Mucormycosis
3
2005
18
0.360
 Why?
RNA, Viral
12
2013
692
0.330
 Why?
Meningococcal Vaccines
2
2012
57
0.330
 Why?
Cardiovirus Infections
2
2000
3
0.320
 Why?
Female
62
2024
79035
0.320
 Why?
Male
53
2024
73003
0.320
 Why?
Viral Vaccines
2
2009
107
0.310
 Why?
Candidemia
2
2023
16
0.310
 Why?
Oxazoles
4
2015
48
0.310
 Why?
Anti-HIV Agents
5
2022
912
0.300
 Why?
Viral Load
7
2017
526
0.290
 Why?
Hepatitis B Vaccines
1
2009
43
0.290
 Why?
AIDS-Related Opportunistic Infections
3
2015
130
0.290
 Why?
Bacterial Vaccines
1
2009
63
0.280
 Why?
Fatigue Syndrome, Chronic
1
2008
19
0.270
 Why?
Pertussis Vaccine
1
2007
24
0.260
 Why?
Communicable Diseases, Emerging
1
2008
39
0.260
 Why?
Poliomyelitis
2
1997
35
0.260
 Why?
Mycetoma
2
2004
7
0.250
 Why?
Immunoglobulins, Intravenous
3
1997
133
0.240
 Why?
Viremia
5
2021
160
0.240
 Why?
Rhinitis
3
2009
169
0.240
 Why?
Fetus
3
2000
804
0.240
 Why?
Antibodies, Viral
5
2022
674
0.210
 Why?
Pregnancy
16
2021
7215
0.210
 Why?
Enterovirus B, Human
3
2001
25
0.210
 Why?
Meningitis, Viral
2
2004
20
0.210
 Why?
Maxillary Sinusitis
2
2004
6
0.210
 Why?
Maus Elberfeld virus
3
1993
5
0.200
 Why?
Anti-Bacterial Agents
3
2013
1925
0.200
 Why?
Cytomegalovirus
2
2016
168
0.190
 Why?
Interferon-gamma
2
2015
784
0.190
 Why?
Acquired Immunodeficiency Syndrome
2
2017
237
0.190
 Why?
Global Health
2
2018
403
0.180
 Why?
Placenta Diseases
2
1995
20
0.180
 Why?
Administration, Intravenous
2
2024
172
0.180
 Why?
Centralized Hospital Services
1
2001
6
0.180
 Why?
Pneumonia, Viral
2
2021
391
0.170
 Why?
Hepatitis, Viral, Human
1
2001
21
0.170
 Why?
Oseltamivir
2
2012
17
0.170
 Why?
Fetal Diseases
3
2000
194
0.170
 Why?
Research Support as Topic
1
2001
81
0.170
 Why?
Colorado
7
2021
4556
0.160
 Why?
Ethmoid Sinusitis
1
1999
1
0.150
 Why?
United States
13
2021
16123
0.150
 Why?
Streptococcus pneumoniae
3
2014
186
0.150
 Why?
Hydrops Fetalis
1
1999
13
0.150
 Why?
Uterine Diseases
1
1999
18
0.150
 Why?
Retrospective Studies
14
2022
17325
0.150
 Why?
Drug Resistance, Microbial
1
1999
64
0.150
 Why?
Intracranial Hemorrhages
1
2000
106
0.150
 Why?
Polymerase Chain Reaction
4
2016
1043
0.150
 Why?
Embryonic Development
1
2000
125
0.150
 Why?
Antibodies, Neutralizing
3
2022
340
0.150
 Why?
Blood Coagulation Disorders
1
2001
198
0.140
 Why?
Biliary Atresia
1
2020
158
0.140
 Why?
Mastoiditis
2
2014
10
0.140
 Why?
Young Adult
14
2017
14251
0.140
 Why?
Treatment Outcome
10
2024
11793
0.140
 Why?
Follow-Up Studies
8
2022
5428
0.140
 Why?
Nervous System Diseases
2
2019
286
0.140
 Why?
Enterovirus D, Human
2
2018
87
0.140
 Why?
Heptavalent Pneumococcal Conjugate Vaccine
2
2009
13
0.140
 Why?
Fluoxetine
1
2018
56
0.140
 Why?
Enzyme-Linked Immunosorbent Assay
2
2013
849
0.140
 Why?
Risk Factors
12
2024
10917
0.140
 Why?
Arboviruses
1
2017
14
0.130
 Why?
Hospitals, Pediatric
1
2001
558
0.130
 Why?
Neurodevelopmental Disorders
1
2021
229
0.130
 Why?
Nucleic Acid Hybridization
6
1991
187
0.130
 Why?
In Situ Hybridization
4
2000
318
0.130
 Why?
Double-Blind Method
3
2015
2064
0.130
 Why?
Acyclovir
2
2015
98
0.130
 Why?
Disease Transmission, Infectious
1
2018
69
0.130
 Why?
HIV-1
2
2015
908
0.130
 Why?
Allografts
1
2018
152
0.130
 Why?
Antibodies, Monoclonal
2
2022
1505
0.130
 Why?
Sexual Maturation
1
2017
48
0.130
 Why?
Cohort Studies
7
2024
6032
0.130
 Why?
Immunization, Passive
1
1997
90
0.120
 Why?
Endoscopy
1
1999
317
0.120
 Why?
Practice Guidelines as Topic
2
2022
1582
0.120
 Why?
Cytomegalovirus Retinitis
1
2016
22
0.120
 Why?
Clinical Trials as Topic
1
2001
1062
0.120
 Why?
Brain
3
2017
2969
0.120
 Why?
Adoption
1
2016
25
0.120
 Why?
Hyperlipidemias
1
2017
120
0.120
 Why?
DNA, Viral
2
2016
356
0.120
 Why?
Gastrointestinal Diseases
1
2018
222
0.120
 Why?
Nasal Mucosa
2
2009
112
0.120
 Why?
Mice, Inbred ICR
4
1997
113
0.120
 Why?
Diagnosis, Differential
2
2017
1512
0.120
 Why?
Lymphocyte Subsets
1
2015
78
0.110
 Why?
Congenital Abnormalities
2
2010
109
0.110
 Why?
Postoperative Complications
2
2016
2977
0.110
 Why?
Respiratory Syncytial Virus Infections
1
1997
139
0.110
 Why?
Sexually Transmitted Diseases
1
2017
168
0.110
 Why?
Ganciclovir
1
2015
53
0.110
 Why?
Chi-Square Distribution
2
2013
528
0.110
 Why?
Child Development
2
2017
483
0.110
 Why?
Muscle Hypotonia
1
2015
34
0.110
 Why?
Lymphopenia
1
2015
62
0.110
 Why?
Oropharynx
1
2015
46
0.110
 Why?
Cranial Nerve Diseases
1
2015
44
0.110
 Why?
Adenovirus Infections, Human
2
1991
15
0.110
 Why?
Adult
17
2022
40872
0.100
 Why?
Incidence
6
2017
2933
0.100
 Why?
Hearing Loss, Sensorineural
1
2015
73
0.100
 Why?
Beclomethasone
1
1993
8
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
27
0.100
 Why?
Puberty, Delayed
1
2013
10
0.100
 Why?
Rectum
1
2015
182
0.100
 Why?
Mycoses
1
2014
88
0.100
 Why?
Antibody Affinity
1
2013
60
0.100
 Why?
Giant Cells
1
1993
21
0.100
 Why?
Hemagglutination Inhibition Tests
1
2013
38
0.100
 Why?
Liver Transplantation
1
2020
826
0.100
 Why?
Cytomegalovirus Infections
1
2015
206
0.090
 Why?
Chickenpox
1
1993
84
0.090
 Why?
Intensive Care Units, Pediatric
1
2015
288
0.090
 Why?
Candida
1
2012
46
0.090
 Why?
Viral Plaque Assay
1
2012
29
0.090
 Why?
Orthomyxoviridae
1
2012
40
0.090
 Why?
Hospital Design and Construction
1
1992
3
0.090
 Why?
Neutralization Tests
1
2012
76
0.090
 Why?
Aircraft
1
1992
22
0.090
 Why?
Bacterial Infections
2
2009
246
0.090
 Why?
CD4-Positive T-Lymphocytes
2
2017
1146
0.090
 Why?
Ureaplasma urealyticum
1
1991
3
0.090
 Why?
HIV
1
2013
251
0.090
 Why?
Severity of Illness Index
4
2021
2933
0.090
 Why?
Drug Resistance, Viral
1
2012
126
0.090
 Why?
Chlamydia trachomatis
1
1991
49
0.090
 Why?
Gestational Age
4
2015
989
0.080
 Why?
Chorioamnionitis
1
1991
50
0.080
 Why?
Peritoneovenous Shunt
1
1990
1
0.080
 Why?
Maternal-Fetal Exchange
2
2007
170
0.080
 Why?
Meningitis, Aseptic
1
1990
13
0.080
 Why?
Poliovirus Vaccine, Oral
1
1990
25
0.080
 Why?
Trophoblasts
1
1993
218
0.080
 Why?
Decision Support Techniques
1
2015
480
0.080
 Why?
Rimantadine
1
2010
1
0.080
 Why?
Prospective Studies
7
2017
8075
0.080
 Why?
Legionnaires' Disease
1
1990
4
0.080
 Why?
Adamantane
1
2010
18
0.080
 Why?
Poliovirus
1
1990
73
0.080
 Why?
Hepatitis B Antibodies
1
2009
6
0.080
 Why?
Biomarkers
1
2021
4302
0.080
 Why?
Cross Infection
1
1992
260
0.070
 Why?
Meningitis
1
1990
80
0.070
 Why?
T-Lymphocytes
2
2015
1997
0.070
 Why?
Respiratory Tract Infections
3
2016
396
0.070
 Why?
Administration, Oral
3
2012
867
0.070
 Why?
Maxillary Sinus
2
2009
11
0.070
 Why?
Mice
8
2000
18355
0.070
 Why?
Age Factors
4
2017
3346
0.070
 Why?
Mucor
2
2005
6
0.070
 Why?
South Africa
1
2009
266
0.070
 Why?
Evidence-Based Medicine
3
2021
740
0.070
 Why?
Drug Administration Schedule
2
2015
782
0.060
 Why?
Body Fluids
1
1987
71
0.060
 Why?
Reverse Transcriptase Inhibitors
1
2007
87
0.060
 Why?
Aspergillosis
2
2014
24
0.060
 Why?
Acute Kidney Injury
1
2015
874
0.060
 Why?
Virus Diseases
1
2009
216
0.060
 Why?
Mitochondrial Diseases
1
2007
92
0.060
 Why?
Zygomycosis
1
2006
6
0.060
 Why?
Carotid Artery Thrombosis
1
2005
6
0.060
 Why?
Organ Transplantation
1
2009
253
0.060
 Why?
Statistics as Topic
1
2006
283
0.060
 Why?
Chronic Disease
5
2009
1812
0.060
 Why?
Logistic Models
2
2023
2139
0.060
 Why?
Antibodies, Monoclonal, Humanized
2
2022
992
0.060
 Why?
Drug Therapy, Combination
2
2007
1043
0.060
 Why?
International Cooperation
2
2018
197
0.050
 Why?
Scedosporium
1
2004
1
0.050
 Why?
Herpesvirus 7, Human
1
2004
6
0.050
 Why?
Drug Resistance, Fungal
1
2004
8
0.050
 Why?
Roseolovirus Infections
1
2004
8
0.050
 Why?
Herpesvirus 6, Human
1
2004
14
0.050
 Why?
Animals
9
2000
38097
0.050
 Why?
Longitudinal Studies
3
2018
2967
0.050
 Why?
Granulocyte Colony-Stimulating Factor
1
2004
90
0.050
 Why?
Respiratory Syncytial Viruses
2
1997
58
0.050
 Why?
Randomized Controlled Trials as Topic
2
2004
1751
0.050
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2004
161
0.050
 Why?
Vaccines, Conjugate
2
2014
59
0.050
 Why?
Infant, Premature, Diseases
2
1997
113
0.050
 Why?
Biological Availability
1
2003
145
0.050
 Why?
Probability
1
2003
308
0.040
 Why?
Risk Assessment
2
2020
3752
0.040
 Why?
Growth Disorders
1
2022
89
0.040
 Why?
Reference Values
1
2003
798
0.040
 Why?
Bacteria, Aerobic
1
2001
7
0.040
 Why?
Case-Control Studies
3
2015
3634
0.040
 Why?
Personnel Staffing and Scheduling
1
2001
98
0.040
 Why?
Disease Models, Animal
3
2000
4568
0.040
 Why?
Drug Combinations
1
2022
396
0.040
 Why?
Income
1
2022
203
0.040
 Why?
Drug Approval
1
2021
93
0.040
 Why?
RNA
2
2022
912
0.040
 Why?
RNA Probes
2
1991
12
0.040
 Why?
Prenatal Exposure Delayed Effects
1
2007
655
0.040
 Why?
Disseminated Intravascular Coagulation
1
2000
34
0.040
 Why?
Adenosine Monophosphate
1
2021
85
0.040
 Why?
United States Food and Drug Administration
1
2021
208
0.040
 Why?
Systemic Inflammatory Response Syndrome
1
2021
95
0.040
 Why?
Alanine
1
2021
169
0.040
 Why?
Fungi
2
2014
121
0.040
 Why?
Necrosis
1
2000
244
0.040
 Why?
Remission Induction
1
2020
306
0.040
 Why?
Picornaviridae Infections
2
1990
53
0.040
 Why?
Otitis Media with Effusion
1
1999
20
0.040
 Why?
Amniotic Fluid
2
1991
79
0.040
 Why?
Cerebrospinal Fluid
2
2004
88
0.040
 Why?
Pharyngitis
1
1999
25
0.040
 Why?
Pseudallescheria
1
1999
3
0.040
 Why?
Zidovudine
2
2010
77
0.040
 Why?
Opportunistic Infections
1
1999
47
0.040
 Why?
Dose-Response Relationship, Drug
1
2003
2028
0.040
 Why?
Time Factors
1
2009
7133
0.030
 Why?
Living Donors
1
2020
282
0.030
 Why?
Spinal Cord
1
2000
382
0.030
 Why?
Chlamydiaceae Infections
1
2017
1
0.030
 Why?
Diabetes Mellitus, Type 1
2
2005
3937
0.030
 Why?
Epidemiological Monitoring
1
2018
70
0.030
 Why?
Nutrition Disorders
1
1997
20
0.030
 Why?
Internationality
1
2018
156
0.030
 Why?
Sex Factors
2
2017
2110
0.030
 Why?
B-Lymphocytes
2
2015
872
0.030
 Why?
Abortion, Spontaneous
1
1997
119
0.030
 Why?
Antigens, Viral
1
2017
182
0.030
 Why?
Ophthalmoscopy
1
2016
38
0.030
 Why?
Heart
1
2000
626
0.030
 Why?
Otitis Media
1
1999
182
0.030
 Why?
Reoperation
1
1999
637
0.030
 Why?
Encephalomyelitis
1
2016
14
0.030
 Why?
Plasma Cells
2
2009
80
0.030
 Why?
Tissue and Organ Procurement
1
2020
343
0.030
 Why?
Acute Disease
1
1999
1036
0.030
 Why?
Enzyme-Linked Immunospot Assay
1
2015
37
0.030
 Why?
Immune Tolerance
2
1999
385
0.030
 Why?
AIDS Dementia Complex
1
2015
52
0.030
 Why?
Molecular Diagnostic Techniques
1
2016
104
0.030
 Why?
North America
1
2016
303
0.030
 Why?
Caribbean Region
1
2015
29
0.030
 Why?
Transplantation, Homologous
1
2016
419
0.030
 Why?
Multicenter Studies as Topic
1
1997
413
0.030
 Why?
Encephalitis, Varicella Zoster
1
2015
17
0.030
 Why?
Encephalitis, Herpes Simplex
1
2015
21
0.030
 Why?
Biopsy
3
2009
1082
0.030
 Why?
Patient Outcome Assessment
1
2016
130
0.030
 Why?
Audiometry
1
2015
35
0.030
 Why?
Physical Conditioning, Animal
1
1997
242
0.030
 Why?
Evaluation Studies as Topic
1
1995
164
0.030
 Why?
Latin America
1
2015
96
0.030
 Why?
Malnutrition
1
2016
86
0.030
 Why?
Odds Ratio
1
2017
1083
0.030
 Why?
Microscopy, Electron
1
1995
414
0.030
 Why?
C-Reactive Protein
1
2017
423
0.030
 Why?
Hematologic Neoplasms
1
2016
168
0.030
 Why?
Coinfection
1
2016
143
0.030
 Why?
Evoked Potentials, Auditory, Brain Stem
1
2015
50
0.030
 Why?
Canada
1
2015
432
0.030
 Why?
Combined Modality Therapy
3
2005
1270
0.030
 Why?
Neutropenia
1
2015
154
0.030
 Why?
Metabolic Diseases
1
2015
114
0.030
 Why?
Infusions, Intravenous
1
2015
428
0.030
 Why?
Multivariate Analysis
1
2017
1547
0.020
 Why?
Papillomavirus Vaccines
1
2017
296
0.020
 Why?
Administration, Intranasal
1
1993
94
0.020
 Why?
Sequence Analysis, DNA
1
2016
778
0.020
 Why?
Sexual Behavior
1
2017
495
0.020
 Why?
Papillomavirus Infections
1
2017
344
0.020
 Why?
T-Lymphocyte Subsets
1
2015
420
0.020
 Why?
Mortality
1
2015
380
0.020
 Why?
Epidemiologic Studies
1
2012
68
0.020
 Why?
Prognosis
1
2001
4329
0.020
 Why?
Oncology Service, Hospital
1
1992
15
0.020
 Why?
Electromyography
1
2015
419
0.020
 Why?
Pandemics
1
2021
1711
0.020
 Why?
Neisseria meningitidis
1
2012
23
0.020
 Why?
Meningococcal Infections
1
2012
26
0.020
 Why?
Infant, Premature
1
1997
620
0.020
 Why?
Tomography, X-Ray Computed
2
1999
2770
0.020
 Why?
Ureaplasma Infections
1
1991
3
0.020
 Why?
Ventilation
1
1992
44
0.020
 Why?
Amniocentesis
1
1991
20
0.020
 Why?
Mycoplasma Infections
1
1991
17
0.020
 Why?
Microbial Viability
1
2012
83
0.020
 Why?
Europe
1
2012
421
0.020
 Why?
Flow Cytometry
1
2015
1165
0.020
 Why?
Adenoviruses, Human
1
1991
26
0.020
 Why?
Hospitals, University
1
1991
176
0.020
 Why?
Lymphocyte Activation
1
2015
1133
0.020
 Why?
Respirovirus Infections
1
1990
14
0.020
 Why?
Anti-Infective Agents
1
2013
232
0.020
 Why?
Comorbidity
1
2016
1662
0.020
 Why?
Paramyxoviridae Infections
1
1990
12
0.020
 Why?
Aged, 80 and over
1
2023
8346
0.020
 Why?
Immunohistochemistry
1
1995
1723
0.020
 Why?
Chlamydia Infections
1
1991
79
0.020
 Why?
Benzoxazines
1
2010
31
0.020
 Why?
Rhinovirus
1
1990
60
0.020
 Why?
Cyclopropanes
1
2010
84
0.020
 Why?
Legionella
1
1990
9
0.020
 Why?
Alkynes
1
2010
67
0.020
 Why?
Cells, Cultured
1
1997
4151
0.020
 Why?
Population Surveillance
1
1993
484
0.020
 Why?
Sensitivity and Specificity
1
1995
2000
0.020
 Why?
Leukemia
1
1992
246
0.020
 Why?
Dermatomyositis
1
1989
24
0.020
 Why?
Inpatients
1
2014
553
0.020
 Why?
Hospitals
1
2014
733
0.020
 Why?
Peroxidase
1
2009
168
0.020
 Why?
Staining and Labeling
1
2009
153
0.020
 Why?
Muscles
1
1989
330
0.020
 Why?
Natural Killer T-Cells
1
2009
71
0.020
 Why?
Respiratory Tract Diseases
1
1990
175
0.020
 Why?
Magnetic Resonance Imaging
2
2015
3915
0.020
 Why?
Picornaviridae
1
1988
18
0.020
 Why?
Seasons
1
1990
538
0.020
 Why?
Ribonucleases
1
1987
48
0.020
 Why?
Central Nervous System
1
2010
282
0.020
 Why?
HIV Reverse Transcriptase
1
2007
31
0.020
 Why?
Lamivudine
1
2007
65
0.020
 Why?
Telencephalon
1
2005
16
0.010
 Why?
Cavernous Sinus
1
2005
16
0.010
 Why?
Antigens, CD
1
2009
558
0.010
 Why?
Orbit
1
2005
66
0.010
 Why?
Infectious Disease Transmission, Vertical
1
2007
194
0.010
 Why?
Paranasal Sinuses
1
2005
81
0.010
 Why?
Cross-Sectional Studies
1
2016
5922
0.010
 Why?
Exocrine Glands
1
2004
5
0.010
 Why?
Basement Membrane
1
2004
32
0.010
 Why?
Cell Count
1
2004
319
0.010
 Why?
Prevalence
1
2010
2874
0.010
 Why?
Neutrophils
1
2009
1125
0.010
 Why?
Lymphocytes
1
2004
376
0.010
 Why?
Eosinophils
1
2004
316
0.010
 Why?
Penicillin Resistance
1
2001
9
0.010
 Why?
Macrophages
1
2009
1507
0.010
 Why?
beta-Lactamases
1
2001
53
0.010
 Why?
Staphylococcus
1
2001
74
0.010
 Why?
Drug Resistance, Multiple, Bacterial
1
2001
77
0.010
 Why?
Haemophilus influenzae
1
2001
68
0.010
 Why?
Drug Resistance, Bacterial
1
2001
185
0.010
 Why?
Nasal Decongestants
1
1999
9
0.010
 Why?
Otorhinolaryngologic Surgical Procedures
1
1999
38
0.010
 Why?
Steroids
1
1999
160
0.010
 Why?
Recurrence
1
1999
1139
0.010
 Why?
Anti-Inflammatory Agents
1
1999
478
0.010
 Why?
Patient Selection
1
1999
739
0.010
 Why?
RNA, Antisense
1
1988
18
0.000
 Why?
DNA, Recombinant
1
1988
48
0.000
 Why?
Sequence Homology, Nucleic Acid
1
1988
157
0.000
 Why?
Virus Replication
1
1988
521
0.000
 Why?
Aged
1
2006
26215
0.000
 Why?
Middle Aged
1
2006
36302
0.000
 Why?
Cell Line
1
1988
2823
0.000
 Why?
DNA
1
1988
1437
0.000
 Why?
Abzug's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (408) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)